Annabidiol Accounts Payable

The latest accounts payable for ACBD is $160K as of December 2024. That compares with $190K in the prior-year period — down 15.3% year over year. Investors often review this figure alongside Annabidiol's historical trend and sector peers before judging valuation or financial health.

Over the past year, ACBD's accounts payable moved from $190K to $160K — a 15.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Annabidiol's operating scale or balance-sheet position.

A accounts payable figure of $160K for ACBD is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting ACBD's accounts payable ($160K), review year-over-year change from $190K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.